BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20503152)

  • 1. Aripiprazole add-on treatment in a patient with schizoaffective disorder: neurocognitive outcomes.
    Pfaffenberger N; Hoertnagl C; Fleischhacker WW; Hofer A
    Pharmacopsychiatry; 2010 Aug; 43(6):234-5. PubMed ID: 20503152
    [No Abstract]   [Full Text] [Related]  

  • 2. Aripiprazole and depression in schizoaffective disorder.
    Errico JR; Yates WR
    Am J Psychiatry; 2005 Mar; 162(3):626-7. PubMed ID: 15741489
    [No Abstract]   [Full Text] [Related]  

  • 3. Aripiprazole in the treatment of olanzapine-resistant psychotic and motor symptoms of Huntington's disease.
    Oulis P; Mourikis I; Konstantakopoulos G; Papageorgiou SG; Kouzoupis AV
    J Neuropsychiatry Clin Neurosci; 2010; 22(3):352c.e4-352.e5. PubMed ID: 20686147
    [No Abstract]   [Full Text] [Related]  

  • 4. Worsening schizoaffective disorder with aripiprazole.
    Reeves RR; Mack JE
    Am J Psychiatry; 2004 Jul; 161(7):1308. PubMed ID: 15229073
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible increased efficacy of low-dose clozapine when combined with aripiprazole.
    Lim S; Pralea C; Schnitt J; Bowers MB; Cooper C
    J Clin Psychiatry; 2004 Sep; 65(9):1284-5. PubMed ID: 15367059
    [No Abstract]   [Full Text] [Related]  

  • 6. Antipsychotic dosing: still a work in progress.
    Remington G
    Am J Psychiatry; 2010 Jun; 167(6):623-5. PubMed ID: 20516160
    [No Abstract]   [Full Text] [Related]  

  • 7. Augmentation of clozapine treatment with aripiprazole.
    Lim S; Bowers MB
    J Clin Psychiatry; 2007 May; 68(5):798-9. PubMed ID: 17503993
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased efficacy with addition of clozapine to aripiprazole: alternative explanations.
    DeQuardo JR
    J Clin Psychiatry; 2005 Mar; 66(3):396; author reply 396. PubMed ID: 15766312
    [No Abstract]   [Full Text] [Related]  

  • 9. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
    Stip E; Tourjman V
    Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manic episode during treatment with aripiprazole.
    Padala PR; Wengel SP; Petty F
    Am J Psychiatry; 2007 Jan; 164(1):172-3. PubMed ID: 17202565
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacology of antipsychotics in the elderly: a focus on atypicals.
    Finkel S
    J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S258-65. PubMed ID: 15541166
    [No Abstract]   [Full Text] [Related]  

  • 12. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
    Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials.
    Kane JM; Barnes TR; Correll CU; Sachs G; Buckley P; Eudicone J; McQuade R; Tran QV; Pikalov A; Assunção-Talbott S
    J Psychopharmacol; 2010 Jul; 24(7):1019-29. PubMed ID: 20008446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical antipsychotics: special formulations for acute agitation.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2005 Oct; 43(10):14-7. PubMed ID: 16294833
    [No Abstract]   [Full Text] [Related]  

  • 15. Datapoints: The ups and downs of dosing second-generation antipsychotics.
    Citrome L; Jaffe A; Levine J
    Psychiatr Serv; 2007 Jan; 58(1):11. PubMed ID: 17215406
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychosis in the elderly.
    Kyomen HH; Whitfield TH
    Am J Psychiatry; 2009 Feb; 166(2):146-50. PubMed ID: 19188291
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychotic episode associated with Bikram yoga.
    Lu JS; Pierre JM
    Am J Psychiatry; 2007 Nov; 164(11):1761. PubMed ID: 17974947
    [No Abstract]   [Full Text] [Related]  

  • 18. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials.
    Glick ID; Mankoski R; Eudicone JM; Marcus RN; Tran QV; Assunção-Talbott S
    J Affect Disord; 2009 May; 115(1-2):18-26. PubMed ID: 19230981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary spastic paraplegia and psychosis: connected by the corpus callosum?
    Osmolak AM; Wallenberg RB; Caplan JP
    Psychosomatics; 2012; 53(1):81-4. PubMed ID: 22118709
    [No Abstract]   [Full Text] [Related]  

  • 20. Aripiprazole plus topiramate in opioid-dependent patients with schizoaffective disorder: an 8-week, open-label, uncontrolled, preliminary study.
    Bruno A; Romeo VM; Pandolfo G; Scimeca G; Zoccali RA; Muscatello MR
    Subst Abus; 2014; 35(2):119-21. PubMed ID: 24821345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.